Drug dosage and remission duration in childhood lymphocytic leukemia

Cancer. 1971 Feb;27(2):247-56. doi: 10.1002/1097-0142(197102)27:2<247::aid-cncr2820270202>3.0.co;2-c.
No abstract available

Publication types

  • Clinical Trial
  • Randomized Controlled Trial

MeSH terms

  • Adolescent
  • Agranulocytosis / chemically induced
  • Antineoplastic Agents / adverse effects
  • Antineoplastic Agents / pharmacology
  • Bone Marrow / drug effects
  • Bone Marrow Cells
  • Child
  • Child, Preschool
  • Cyclophosphamide / administration & dosage*
  • Humans

Substances

  • Antineoplastic Agents
  • Cyclophosphamide